OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
XEN$0.0054

Xenitra Ltd

Food Retail & DistributionVerified

Xenitra Ltd has a market capitalization of $7.73 million, with a market price of $0.002 per share, and 3.86 billion shares outstanding, both basic and diluted. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Xenitra, as the valuation snapshot does not include return on invested capital (ROIC), gross margins, or net margins. This lack of data prevents a direct comparison to industry_config preferred metrics or cohort medians. Segment and geographic exposure details are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory is difficult to determine due to the absence of historical revenue data and forward-looking outlooks. The outlook section does not provide numeric deltas for the current or next fiscal year. Risk factors include a low dilution potential, with no significant dilution sources identified in the risk assessment. However, the lack of balance-sheet inputs and going-concern language in source documents raises concerns about the company's financial health and operational continuity. Recent events, such as filings or transcripts, are not disclosed in the available data, limiting the ability to assess the company's recent performance or strategic direction.

30-day price · XEN(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyXenitra Ltd
TickerXEN.AX
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Xenitra Ltd operates in the Food & Drug Retailing industry, providing retail services for food and drug products to consumers.

Classification. Xenitra is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.

Xenitra Ltd has a market capitalization of $7.73 million, with a market price of $0.002 per share, and 3.86 billion shares outstanding, both basic and diluted. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Xenitra, as the valuation snapshot does not include return on invested capital (ROIC), gross margins, or net margins. This lack of data prevents a direct comparison to industry_config preferred metrics or cohort medians. Segment and geographic exposure details are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory is difficult to determine due to the absence of historical revenue data and forward-looking outlooks. The outlook section does not provide numeric deltas for the current or next fiscal year. Risk factors include a low dilution potential, with no significant dilution sources identified in the risk assessment. However, the lack of balance-sheet inputs and going-concern language in source documents raises concerns about the company's financial health and operational continuity. Recent events, such as filings or transcripts, are not disclosed in the available data, limiting the ability to assess the company's recent performance or strategic direction.
Key takeaways
  • Xenitra Ltd has a very low market capitalization of $7.73 million, indicating a small market presence.
  • The company's liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Profitability and return metrics are not available, making it difficult to evaluate the company's financial performance.
  • No segment or geographic exposure data is disclosed, limiting the understanding of revenue concentration and diversification.
  • Growth trajectory and recent events are not quantifiable due to the absence of relevant data in the provided sources.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$14.3M-$18.9M-$20.1M-$22.2M
FY-3$6.9M-$5.9M-$6.1M-$4.9M
FY-2$2.8M-$2.8M-$3.0M-$2.5M
FY-1$26.0M-$6.2M-$6.3M-$6.0M
FY0$39.9M-$3.4M-$3.5M-$3.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$17.3M$5.4M
FY-3$10.1M$4.2M
FY-2$6.4M$5.1M
FY-1$4.4M$524.7k$2.0M
FY0$8.3M$2.5M$1.7M
PeriodOCFCapExFCFSBC
FY-4-$8.0M-$2.5M-$22.2M
FY-3-$2.4M-$131.7k-$4.9M
FY-2-$3.5M$0.00-$2.5M
FY-1-$2.6M-$190.0k-$6.0M
FY0-$4.3M-$6.9k-$3.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$0.00
Market cap$7.7M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricXENActivity
Op margin3.1% medp25 1.2% · p75 6.8%
Net margin2.0% medp25 0.7% · p75 4.1%
Gross margin26.1% medp25 17.2% · p75 32.0%
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity56.0% medp25 16.8% · p75 121.1%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 01:13 UTC#e1806a16
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 01:46 UTCJob: 2e9ff06b